首页ARX • ASX
add
Aroa Biosurgery Ltd
市场资讯
财务信息
损益表
收入
净收入
| (NZD) | 2025年3月info | 年同比变化 |
|---|---|---|
收入 | 2277.05万 | 22.44% |
经营支出 | 1831.25万 | -1.38% |
净收入 | -25.95万 | 87.99% |
净利润率 | -1.14 | 90.19% |
每股收益 | — | — |
息税折旧摊销前利润 | 179.72万 | 206.79% |
有效税率 | -50.43% | — |
资产负债表
总资产
负债总额
| (NZD) | 2025年3月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 2214.90万 | -26.72% |
总资产 | 1.09亿 | -1.97% |
负债总额 | 1578.70万 | -2.06% |
权益总额 | 9308.50万 | — |
发行在外的股份 | 3.45亿 | — |
市净率 | 2.04 | — |
资产回报率 | 2.31% | — |
资本回报率 | 2.52% | — |
现金流
现金净变动
| (NZD) | 2025年3月info | 年同比变化 |
|---|---|---|
净收入 | -25.95万 | 87.99% |
来自运营的现金 | 115.15万 | 3,212.16% |
投资现金 | -375.40万 | -191.43% |
融资现金 | -37.60万 | -57.32% |
现金净变动 | -280.45万 | -174.12% |
自由现金流 | 286.69万 | 1,633.63% |
简介
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
成立时间
2008
网站
员工数量
261
